Paychex, Inc. — Form 10-Q Summary
Business context and reporting period
Paychex provides human capital management, payroll, HR, benefits, insurance, and PEO solutions primarily to small and medium-sized businesses in the United States, with operations in parts of Europe. The filing covers the quarter and six months ended November 30, 2021, representing fiscal 2022 second quarter and year-to-date results. The company reports one operating segment.
Financial performance and position
| Metric | Q2 FY2022 | Q2 FY2021 | Six months FY2022 | Six months FY2021 |
|---|---|---|---|---|
| Total revenue | $1,108.5 million | $983.7 million | $2,191.4 million | $1,915.9 million |
| Service revenue | $1,094.4 million | $968.9 million | $2,162.8 million | $1,886.2 million |
| Operating income | $440.3 million | $354.3 million | $883.2 million | $638.3 million |
| Net income | $332.1 million | $272.4 million | $665.7 million | $484.0 million |
| Diluted EPS | $0.91 | $0.75 | $1.83 | $1.34 |
| Operating margin | 39.7% | 36.0% | 40.3% | 33.3% |
- Management Solutions revenue increased 14% in the quarter and 15% year to date, driven by higher checks per payroll, improved pricing, client-base growth, retention, improved retirement-services market conditions, and increased temporary-staffing funding.
- PEO and Insurance Solutions revenue increased 11% in the quarter and 13% year to date, reflecting more worksite employees, higher average wages, increased health-insurance revenue, and higher state unemployment-insurance revenue.
- Interest on funds held for clients declined 5% in the quarter and 4% year to date as average investment yields decreased.
- Operating expenses increased 6% in the quarter and 2% year to date. Excluding $32.2 million of prior-year cost-saving initiative charges, year-to-date expenses increased 5%.
- Effective tax rates increased to 24.1% from 22.1% in the quarter and to 24.5% from 22.7% year to date, primarily due to lower stock-compensation-related tax benefits and higher state taxes.
- Year-to-date operating cash flow was $555.4 million, compared with $430.7 million in the prior-year period. Investing cash use was $451.4 million and financing cash use was $302.9 million.
- Dividends paid increased 7% to $476.4 million year to date; the quarterly dividend increased from $0.62 to $0.66 per share.
- Cash, restricted cash, and equivalents totaled $1.624 billion at November 30, 2021. Corporate cash, restricted cash, and investments totaled approximately $1.1 billion, excluding client funds.
- Total borrowings were $806.4 million, consisting primarily of $800 million of unsecured Senior Notes and $8.9 million of short-term borrowings, net of debt issuance costs where applicable. Approximately $2.0 billion remained available under committed credit facilities.
Material changes versus the prior comparable period
- Revenue growth accelerated across both service categories, supported by economic recovery, higher client payroll volumes, pricing, client retention, and worksite-employee growth.
- Operating income rose 24% in the quarter and 38% year to date, while net income rose 22% and 38%, respectively. The year-to-date comparison benefited from $32.2 million of one-time cost-saving charges recorded in the prior year.
- Net unrealized gains on available-for-sale securities declined to $35.9 million from $79.3 million at May 31, 2021, primarily reflecting interest-rate movements. Securities fair value increased to $3.317 billion from $3.020 billion.
- Accounts receivable increased to $817.0 million from $578.3 million, and PEO unbilled receivables increased to $531.8 million from $450.9 million, primarily reflecting increased temporary-staffing funding and business growth.
- The company completed an immaterial acquisition in October 2021 that added a benefits-administration software platform.
- No common shares were repurchased during the six months, compared with $28.8 million of repurchases in the prior-year period. Approximately $472.4 million remained available under the repurchase programs.
Guidance, outlook, risks, and unusual items
- The filing does not provide a clear formal revenue or EPS guidance range. Management states that cash, investments, projected operating cash flow, and available financing are expected to support operations, capital purchases, share repurchases, and dividends for the foreseeable future.
- Management expects the total investment portfolio to average approximately $5.5 billion in fiscal 2022, with approximately 40% in short-term securities and variable-rate demand notes and 60% in available-for-sale securities.
- A 25-basis-point change in short-term interest rates is estimated to affect after-tax earnings by approximately $3.0 million to $3.5 million over a twelve-month period. A hypothetical 25-basis-point increase in longer-term rates would reduce the fair value of the available-for-sale portfolio by approximately $25 million, with the impact generally recorded in equity unless credit impairment occurs.
- COVID-19 continues to create uncertainty for small and medium-sized business clients, operating conditions, and future cash flows. Management reported strong sales, retention, payroll volumes, and earnings despite the continuing pandemic.
- Key risks include cybersecurity and data privacy, system outages, third-party service failures, technology and software defects, PEO co-employment and insurance claims, workers’ compensation and health-insurance trends, client reimbursement and credit risk, regulatory changes, acquisitions, litigation, and failure to comply with debt covenants.
- Workers’ compensation and health-insurance reserves rely on actuarial estimates and could change materially as claims experience, legal standards, economic conditions, or damage awards change.
- The company reported no goodwill or intangible-asset impairment and no material credit-loss provision on its investment securities. It believed unrealized investment losses were interest-rate-related rather than credit-related.
- Credit facilities were amended in September 2021: one JPMorgan facility increased from $500 million to $750 million and was extended to September 2026; the amendments also address the phaseout of LIBOR. The company was in compliance with its debt covenants.
Important facts for investors to verify
- Reconcile reported growth with the prior-year one-time cost-saving charges when assessing underlying margin and earnings trends.
- Monitor interest rates, investment yields, unrealized gains and losses, and the sensitivity of earnings to changes in short-term rates.
- Assess the quality and collectability of the significant increase in accounts receivable, including purchased receivables related to temporary-staffing clients.
- Review PEO insurance reserves, worksite-employee growth, and claims trends for potential earnings volatility.
- Confirm the impact and integration progress of the October 2021 benefits-administration acquisition.
- Evaluate capital allocation, including the $0.66 quarterly dividend, available share-repurchase authorization, $800 million of Senior Notes, and available credit capacity.
- Review cybersecurity, privacy, regulatory, COVID-19, litigation, and client-credit disclosures in the company’s Form 10-K and subsequent filings.